Банкеръ Weekly

Briefs

SOPHARMA BUYS ITS KAZANLUK-BASED RIVAL

The pharmaceutical company Sopharma will acquire a majority package (up to 95%) of shares in the Kazanluk-based Bulgarian Rose - Sevtopolis immediately after rge Commission for Protection of Competition (CPC) allows the deal. This will practically put an end to their 10-year-long dispute about...
Facebook logo
Бъдете с нас и във